Company / EPS (Diluted)
Design Therapeutics, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.88
FY2025
5-year range
-$1.19 / -$0.52
FY2021-FY2025
Trend
+26.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.52 to $-0.88 over the past 4 years.
Based on SEC 10-K filings.
-0.88 in FY2025.
Declined from $-0.52 to $-0.88 over the past 4 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 26.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.88 | +26.1% |
| FY2024 | -$1.19 | -128.8% |
| FY2021 | -$0.52 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026